Skip to content

Exploring how gentle vaginal laser treatment may help women with pelvic floor problems

Anatomical and functional effects of non-ablative vaginal laser in women with pelvic floor dysfunction: a prospective single-arm interventional study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ISRCTN
Registry ID
ISRCTN11575756
Enrollment
163
Registered
2025-11-18
Start date
2024-01-27
Completion date
Unknown
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pelvic floor dysfunction Musculoskeletal Diseases

Interventions

The intervention consisted of IncontiLase® and IntimaLase® protocols delivered with the SP DYNAMIS system (S/N 14003339), aiming for controlled mucosal heating to approximately 65 °C to promote tissue
analgesia was provided as needed, eye protection and antiseptic preparation were used, and standard post-procedure instructions were given. The total pulse energy delivered to the anterior wall, poste
transient post-procedural sensations (local warmth, mild stinging, watery discharge, transient vulvovaginal erythema/edema) were recorded separately from adverse events (persistent pain, dysuria, vagi

Sponsors

RAPbarcelona, Spain
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1. Women self-reported symptoms of pelvic floor dysfunction, which could include urinary incontinence, pelvic organ prolapse, or sexual dysfunction. 2. They perceived vaginal laxity, defined as a score of 4 or higher on the Vaginal Laxity Questionnaire (VLQ). 3. They were able to complete validated questionnaires used in the study. 4. They provided written informed consent to participate. 5. They authorized the use of their anonymized clinical data for research purposes.

Exclusion criteria

Exclusion criteria: 1. Previous vaginal laser therapy 2. Contraindications to non-ablative vaginal laser 3. Concomitant interventions expected to confound outcomes during the evaluation period, such as pelvic floor physiotherapy, vaginal radiofrequency, or other concurrent treatments

Design outcomes

Primary

MeasureTime frame
At baseline (prior to the first laser session), follow-up 1 (6–8 weeks after the first session), follow-up 2 (6–8 weeks after the second session): 1. The vaginal hiatus was assessed following the criteria set forth by the joint report of the International Continence Society and the International Urogynecological Association (ICS/IUGA) on terminology for female pelvic floor dysfunction 2. Total vaginal length was defined as the distance in centimeters from the posterior fornix to the hymen, with point C or D reduced to its normal position.

Secondary

MeasureTime frame
At baseline (prior to the first laser session), follow-up 1 (6–8 weeks after the first session), follow-up 2 (6–8 weeks after the second session): 1. Pelvic floor muscle strength was assessed by vaginal palpation using the Oxford scale 2. Sexual function was evaluated with the self-administered Female Sexual Function Index (FSFI), which assesses six domains (desire, arousal, lubrication, orgasm, satisfaction, pain)

Countries

Spain

Contacts

Public ContactInés Ramirez Garcia
inesrg@blanquerna.url.edu+34 677745765

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026